Minimal residual disease testing is performed to detect and quantify small numbers of cancer cells in a patient’s body. It includes sensitive technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and flow cytometry to identify residual disease at the molecular level. Minimal residual disease testing is clinically important because it helps monitor response […]